News | 28/11/2025

Hope for a cure for cancer - BZKF study registry bundles around 1,000 studies

Cancer patients can find online access to innovative therapies and supportive care. offers - targeted and close to home
When a cancer diagnosis turns life upside down, many patients begin an often long journey through treatment, uncertainty and questions. In addition to regular therapy, clinical trials offer an important opportunity: they provide access to new, promising treatment options - often years before they become widely available. To make it easier for patients in Bavaria to find their way to such studies, the Bavarian Center for Cancer Research (BZKF) has set up a central study registry for Bavaria. Since its launch in November 2022, the service has been growing steadily - around 1,000 clinical oncology studies are now recorded and accessible to all interested parties via the website studien.bzkf.de. In order to facilitate access to these studies for patients and doctors, more than 1,700 contact details for the currently recruiting studies are stored in the BZKF study registry.

At the launch of the project in 2022, Science Minister Markus Blume emphasized the importance of the trial registry as a "navigator" for those affected. The study register serves as a valuable orientation aid in an often stressful phase of life. The study register allows studies to be filtered according to disease, place of residence or type of treatment - simply and clearly. Anyone wishing to be included in a study can find out in advance about the requirements and find out at which clinics the respective study is being conducted.

Hope through cancer research

"Whether it's new drugs, help against side effects or psychological support - behind every study is potential progress. Studies can mean real opportunities for patients. Anyone who is unsure about finding suitable studies should ask the treatment team for help - because doctors are also called upon to actively use and pass on such information," says Prof. Dr. Claus Belka, Deputy Director of the BZKF and Director of the Department of Radiotherapy at LMU Klinikum München.

Early clinical trial unit for Bavaria

"The development of new drugs and therapies is based on innovative preclinical research and clinical testing.testing. The BZKF's Early Clinical Trial Units (ECTU) play a decisive role here by enabling the safe application of experimental cancer treatment.application of experimental cancer treatment. The BZKF study registry provides a clear and comprehensible overview of the various studies," explains Dr. Maria-Elisabeth Goebeler, Head Senior Physician of theInterdisciplinary Study Center with ECTU.

Early Clinical Trial Unit (ECTU) at the LMU Hospital

Prof. Claus Belka, Deputy Director of the BZKF and Director of the Department of Radiotherapy at LMU Hospital, on the milestone "1,000 studies in theBZKF study register".

Further information

The study register at studien.bzkf.de is intended to show those affected new perspectives. Talk to your treating doctor or use the BürgerTelefonKrebs service on the free telephone number 0800 85 100 80 to ask questions about cancer. For questions about clinicalclinical trials, you can contact the ECTU team by e-mail at BZKF_ECTU_Koordination@ukw.de.

Originally translated with DeepL